查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1601019

肝病诊断市场：按诊断方法和最终用户划分 - 全球预测 2025-2030

Liver Disease Diagnostics Market by Diagnosis Technique (Biopsy, Endoscopy, Imaging), End-user (Hospitals, Laboratories) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年肝病诊断市值为99.4亿美元，预计2024年将达到110.9亿美元，复合年增长率为12.76%，预计到2030年将达到230.5亿美元。

肝病诊断市场专注于诊断肝病的工具和测试，包括肝炎、肝硬化和肝癌。它包括生物化学检验、诊断影像技术和分子诊断，对于早期疾病检测、监测进展和评估治疗效果至关重要。由于饮酒、肥胖和病毒感染等因素导致肝病盛行率不断增加，因此需要进行此类诊断。该市场针对医院、诊断实验室和研究机构等医疗保健环境，并强调对个人化医疗和非侵入性技术不断增长的需求作为关键应用。

主要市场统计
基准年[2023] 99.4亿美元
预测年份 [2024] 110.9亿美元
预测年份 [2030] 230.5亿美元
复合年增长率（%） 12.76%

影响市场的主要成长要素包括技术进步、对肝病认识的提高以及对准确诊断的需求激增。基因组学和蛋白​​质组学的创新为更准确的诊断铺平了道路，并增加了标靶治疗的潜力。随着人工智慧主导的诊断工具的发展，最近出现了一些趋势，这些工具提高了准确性并加快了诊断过程。此外，生物技术公司和医疗保健提供者之间的合作正在促进新诊断解决方案的快速开发和实施。

引进挑战包括先进诊断测试的高成本、熟练专业人员的有限性以及减缓新技术采用的监管障碍。製药公司还必须考虑习惯于既定诊断方法的临床社群的潜在阻力。为了优化成长，创新应着重于经济高效、准确且易于部署的诊断工具。将肝臟微型RNA作为生物标记进行研究、改进成像技术以及用于资料分析的机器学习应用程式是业务扩展的有希望的途径。

总而言之，由于技术进步和对精准医疗日益增长的需求，肝病诊断市场具有巨大的成长潜力。透过解决成本和监管挑战以及投资尖端研究，公司可以抓住新机会并巩固其市场地位。

市场动态：快速发展的肝病诊断市场的关键市场洞察

供需的动态交互作用正在改变肝病诊断市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 急性和慢性肝病盛行率增加
    • 制定政府和非政府意识计划
    • 消费者对微创诊断系统的倾向
  • 市场限制因素
    • 诊断设备高成本且缺乏熟练的专业人员
  • 市场机会
    • 诊断系统的技术进步
    • 改善经济体的医疗保健可近性
  • 市场挑战
    • 肝臟诊断系统的复杂性

波特五力策略工具引领肝病诊断市场

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对肝病诊断市场的影响

外部宏观环境因素在塑造肝病诊断市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解肝病诊断市场的竞争状况

肝病诊断市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵肝病诊断市场供应商绩效评估

FPNV定位矩阵是评估肝病诊断市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：全面分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 急性和慢性肝病盛行率增加
      • 制定政府和非政府意识计划
      • 消费者对微创诊断系统的趋势
    • 抑制因素
      • 诊断设备高成本且缺乏熟练的专业人员
    • 机会
      • 诊断系统的技术进步
      • 改善经济中的医疗保健服务
    • 任务
      • 与肝臟诊断系统相关的复杂性
  • 市场区隔分析
    • 诊断技术：改善肝臟疾病诊断影像方法的持续进展
    • 最终用户：政府努力建立强大的医疗基础设施，扩大了世界各地的医院规模
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依诊断技术分類的肝病诊断药物市场

  • 切片检查
  • 内视镜检查
  • 影像
  • 临床检查

第七章肝病诊断市场：依最终使用者分类

  • 医院
  • 研究所

第八章北美、南美洲肝病诊断药物市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区肝病诊断市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲的肝病诊断市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • E-Spicics 开始在美国商业销售肝臟内视镜，并在美国开设子公司。
    • Stone Diagnostics 提供纤维化肝病检测
    • 预测健康情报推出针对未确诊肝病的工具

公司名单

  • Abbott Laboratories
  • Bayer AG
  • Merck & Co., Inc.
  • Boston Scientific Corporation
  • Randox Laboratories Ltd.
  • Fujifilm Holdings Corporation
  • Perspectum Ltd.
  • Koninklijke Philips NV
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories, Inc.
  • Laboratory Corporation of America Holdings
  • BioMerieux SA
  • Cook Medical Incorporated
  • Siemens Healthineers AG
  • Horiba, Ltd.
  • Becton, Dickinson and Company
  • Ri.Mos. Srl
  • Hepatiq, Inc.
  • Hologic, Inc.
  • Argon Medical Devices, Inc.
  • Epigenomics AG
  • Medtronic PLC
  • Thermo Fisher Scientific, Inc.
  • Quest Diagnostics Incorporated
Product Code: MRR-B9334AD6C587

The Liver Disease Diagnostics Market was valued at USD 9.94 billion in 2023, expected to reach USD 11.09 billion in 2024, and is projected to grow at a CAGR of 12.76%, to USD 23.05 billion by 2030.

The Liver Disease Diagnostics market focuses on tools and tests to diagnose liver diseases, including hepatitis, cirrhosis, and liver cancer. It involves biochemical tests, imaging techniques, and molecular diagnostics, essential for early disease detection, monitoring progression, and assessing treatment efficacy. The necessity of such diagnostics lies in the increasing prevalence of liver diseases driven by factors like alcohol consumption, obesity, and viral infections. The market serves healthcare settings, including hospitals, diagnostic labs, and research institutes, emphasizing personalized medicine and the rising demand for non-invasive techniques as critical applications.

KEY MARKET STATISTICS
Base Year [2023] USD 9.94 billion
Estimated Year [2024] USD 11.09 billion
Forecast Year [2030] USD 23.05 billion
CAGR (%) 12.76%

Key growth factors influencing the market include advancements in technology, increasing awareness of liver conditions, and burgeoning demand for accurate diagnostic procedures. Innovations in genomics and proteomics are paving the way for more precise diagnostics, enhancing the potential for targeted therapies. Recent opportunities are emerging in the development of AI-driven diagnostic tools that improve accuracy and speed up the diagnostic process. Additionally, collaborations between biotech firms and healthcare providers are fostering the rapid development and adoption of novel diagnostic solutions.

Challenges include the high cost of advanced diagnostic tests, limited availability of skilled professionals, and regulatory hurdles that can slow down the introduction of new technologies. Pharmaceutical companies must also consider the potential resistance from a clinical community accustomed to established diagnostic methods. To optimize growth, innovation should focus on cost-effective, highly accurate, and easily deployable diagnostic tools. Research into liver microRNA as biomarkers, improved imaging technologies, and machine learning applications for data analysis are promising avenues for business expansion.

In essence, the liver disease diagnostics market holds significant growth potential, driven by technological advancements and an increasing need for precision medicine. By addressing cost and regulatory challenges and investing in cutting-edge research, companies can capture emerging opportunities and strengthen their market position.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Liver Disease Diagnostics Market

The Liver Disease Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in the Prevalence of Acute and Chronic Liver Diseases
    • Development of Government and Non-Government Awareness Programs
    • Consumer Inclination Towards Minimally Invasive Diagnostic Systems
  • Market Restraints
    • High Cost of Diagnostic Devices and Lack of Skilled Professionals
  • Market Opportunities
    • Technological Advancements in Diagnostic Systems
    • Improving Healthcare Access in Economies
  • Market Challenges
    • Complexity Associated with Liver Diagnostic Systems

Porter's Five Forces: A Strategic Tool for Navigating the Liver Disease Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Liver Disease Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Liver Disease Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Liver Disease Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Liver Disease Diagnostics Market

A detailed market share analysis in the Liver Disease Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Liver Disease Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Liver Disease Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Liver Disease Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Bayer AG, Merck & Co., Inc., Boston Scientific Corporation, Randox Laboratories Ltd., Fujifilm Holdings Corporation, Perspectum Ltd., Koninklijke Philips N.V., Amgen Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Laboratory Corporation of America Holdings, BioMerieux SA, Cook Medical Incorporated, Siemens Healthineers AG, Horiba, Ltd., Becton, Dickinson and Company, Ri.Mos. Srl, Hepatiq, Inc., Hologic, Inc., Argon Medical Devices, Inc., Epigenomics AG, Medtronic PLC, Thermo Fisher Scientific, Inc., and Quest Diagnostics Incorporated.

Market Segmentation & Coverage

This research report categorizes the Liver Disease Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Diagnosis Technique, market is studied across Biopsy, Endoscopy, Imaging, and Laboratory Tests.
  • Based on End-user, market is studied across Hospitals and Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in the Prevalence of Acute and Chronic Liver Diseases
      • 5.1.1.2. Development of Government and Non-Government Awareness Programs
      • 5.1.1.3. Consumer Inclination Towards Minimally Invasive Diagnostic Systems
    • 5.1.2. Restraints
      • 5.1.2.1. High Cost of Diagnostic Devices and Lack of Skilled Professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological Advancements in Diagnostic Systems
      • 5.1.3.2. Improving Healthcare Access in Economies
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity Associated with Liver Diagnostic Systems
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Diagnosis Technique: Ongoing advances to improve imaging modalities for liver disease diagnosis
    • 5.2.2. End-user: Expansion of hospitals across the world supported by government initiatives for developing robust healthcare infrastructure
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Liver Disease Diagnostics Market, by Diagnosis Technique

  • 6.1. Introduction
  • 6.2. Biopsy
  • 6.3. Endoscopy
  • 6.4. Imaging
  • 6.5. Laboratory Tests

7. Liver Disease Diagnostics Market, by End-user

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Laboratories

8. Americas Liver Disease Diagnostics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Liver Disease Diagnostics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Liver Disease Diagnostics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. E-Scopics Announces Commercial Launch Of Hepatoscope in the Us And Opens its Subsidiary in the US
    • 11.3.2. Stone Diagnostics to Provide Fibronostics Liver Disease Test
    • 11.3.3. Predictive Health Intelligence Launches Tool For Undiagnosed Liver Disease

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Bayer AG
  • 3. Merck & Co., Inc.
  • 4. Boston Scientific Corporation
  • 5. Randox Laboratories Ltd.
  • 6. Fujifilm Holdings Corporation
  • 7. Perspectum Ltd.
  • 8. Koninklijke Philips N.V.
  • 9. Amgen Inc.
  • 10. F. Hoffmann-La Roche Ltd.
  • 11. Bio-Rad Laboratories, Inc.
  • 12. Laboratory Corporation of America Holdings
  • 13. BioMerieux SA
  • 14. Cook Medical Incorporated
  • 15. Siemens Healthineers AG
  • 16. Horiba, Ltd.
  • 17. Becton, Dickinson and Company
  • 18. Ri.Mos. Srl
  • 19. Hepatiq, Inc.
  • 20. Hologic, Inc.
  • 21. Argon Medical Devices, Inc.
  • 22. Epigenomics AG
  • 23. Medtronic PLC
  • 24. Thermo Fisher Scientific, Inc.
  • 25. Quest Diagnostics Incorporated

LIST OF FIGURES

  • FIGURE 1. LIVER DISEASE DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. LIVER DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. LIVER DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. LIVER DISEASE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. LIVER DISEASE DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY ENDOSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. LIVER DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. LIVER DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023